USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIβ subunit of cAMP-dependent protein kinase

por Dahle, Maria Krudtaa, Taskén, Kjetil, Taskén, Kristin Austlid
Publicado 2002

Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence

por Sivanesan, Shivanthe, Taskén, Kristin Austlid, Grytli, Helene Hartvedt
Publicado 2022

Regulation of PBX3 expression by androgen and Let-7d in prostate cancer

por Ramberg, Håkon, Alshbib, Ayham, Berge, Viktor, Svindland, Aud, Taskén, Kristin Austlid
Publicado 2011

TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells

por Eide, Turid, Ramberg, Håkon, Glackin, Carlotta, Tindall, Donald, Taskén, Kristin Austlid
Publicado 2013

β-Adrenergic Receptor Signaling in Prostate Cancer

por Braadland, Peder Rustøen, Ramberg, Håkon, Grytli, Helene Hartvedt, Taskén, Kristin Austlid
Publicado 2015

Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer

por Arstad, Christian, Taskén, Kristin, Refinetti, Paulo, Axcrona, Ulrika, Giercksky, Karl-Erik, Ekstrøm, Per Olaf
Publicado 2020

Implication of β2-adrenergic receptor and miR-196a correlation in neurite outgrowth of LNCaP prostate cancer cells

por Guerriero, Ilaria, Ramberg, Håkon, Sagini, Krizia, Ramirez-Garrastacho, Manuel, Taskén, Kristin A., Llorente, Alicia
Publicado 2021

Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research

por Ramirez-Garrastacho, Manuel, Bajo-Santos, Cristina, Line, Aija, Martens-Uzunova, Elena S., de la Fuente, Jesus Martinez, Moros, Maria, Soekmadji, Carolina, Tasken, Kristin Austlid, Llorente, Alicia
Publicado 2021

Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructiv...

por Berg, Janna, Halvorsen, Ann Rita, Bengtson, May-Bente, Taskén, Kristin A., Mælandsmo, Gunhild M., Yndestad, Arne, Halvorsen, Bente, Brustugun, Odd Terje, Aukrust, Pål, Ueland, Thor, Helland, Åslaug
Publicado 2018

Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer

por Guldvik, Ingrid Jenny, Braadland, Peder Rustøen, Sivanesan, Shivanthe, Ramberg, Håkon, Kristensen, Gitte, Tennstedt, Pierre, Røder, Andreas, Schlomm, Thorsten, Berge, Viktor, Eri, Lars Magne, Lilleby, Wolfgang, Mills, Ian G., Taskén, Kristin Austlid
Publicado 2022

Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer

por Ramberg, Håkon, Richardsen, Elin, de Souza, Gustavo A, Rakaee, Mehrdad, Stensland, Maria Ekman, Braadland, Peder Rustøen, Nygård, Ståle, Ögren, Olov, Guldvik, Ingrid J, Berge, Viktor, Svindland, Aud, Taskén, Kristin A, Andersen, Sigve
Publicado 2021

Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy

por Moghaddam, Shirin, Jalali, Amirhossein, O’Neill, Amanda, Murphy, Lisa, Gorman, Laura, Reilly, Anne-Marie, Heffernan, Áine, Lynch, Thomas, Power, Richard, O’Malley, Kieran J., Taskèn, Kristin A., Berge, Viktor, Solhaug, Vivi-Ann, Klocker, Helmut, Murphy, T. Brendan, Watson, R. William
Publicado 2021

Low β(2)-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism

por Braadland, Peder Rustøen, Grytli, Helene Hartvedt, Ramberg, Håkon, Katz, Betina, Kellman, Ralf, Gauthier-Landry, Louis, Fazli, Ladan, Krobert, Kurt Allen, Wang, Wanzhong, Levy, Finn Olav, Bjartell, Anders, Berge, Viktor, Rennie, Paul S., Mellgren, Gunnar, Mælandsmo, Gunhild Mari, Svindland, Aud, Barbier, Olivier, Taskén, Kristin Austlid
Publicado 2015

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

por Guldvik, Ingrid J., Zuber, Verena, Braadland, Peder R., Grytli, Helene H., Ramberg, Håkon, Lilleby, Wolfgang, Thiede, Bernd, Zucknick, Manuela, Saatcioglu, Fahri, Gislefoss, Randi, Kvåle, Rune, George, Anne, Grönberg, Henrik, Wiklund, Fredrik, Neal, David E., Gnanapragasam, Vincent J., Taskén, Kristin A., Mills, Ian G.
Publicado 2020

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

por Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt
Publicado 2017

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

por Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt
Publicado 2018

The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource

por Ouellet, Véronique, Erickson, Andrew, Wiley, Kathy, Morrissey, Colm, Berge, Viktor, Moreno, Carlos S., Tasken, Kristin Austlid, Trudel, Dominique, True, Lawrence D., Lewis, Michael S., Svindland, Aud, Ertunc, Onur, Vidal, Igor Damasceno, Osunkoya, Adeboye O., Jones, Tracy, Bova, G. Steven, Lamminen, Tarja, Achtman, Ariel H., Buzza, Mark, Kouspou, Michelle M., Bigler, Steven A., Zhou, Xinchun, Freedland, Stephen J., Mes-Masson, Anne-Marie, Garraway, Isla P., Trock, Bruce J., Taimen, Pekka, Saad, Fred, Mirtti, Tuomas, Knudsen, Beatrice S., De Marzo, Angelo M.
Publicado 2022